MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 75 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,557,569 | +10410.7% | 3,374,101 | +10919.3% | 0.00% | – |
Q1 2023 | $24,333 | +63.7% | 30,620 | -18.6% | 0.00% | – |
Q4 2022 | $14,862 | -73.5% | 37,626 | -6.5% | 0.00% | – |
Q3 2022 | $56,000 | -86.2% | 40,259 | -71.2% | 0.00% | – |
Q1 2022 | $406,000 | +728.6% | 140,001 | +1161.3% | 0.00% | – |
Q4 2021 | $49,000 | -43.0% | 11,100 | -5.9% | 0.00% | – |
Q3 2021 | $86,000 | -93.6% | 11,800 | -91.5% | 0.00% | – |
Q2 2021 | $1,352,000 | -85.3% | 138,267 | -82.2% | 0.00% | -100.0% |
Q1 2021 | $9,181,000 | +1063.6% | 775,414 | +670.6% | 0.00% | – |
Q4 2020 | $789,000 | +55.9% | 100,621 | +35.1% | 0.00% | – |
Q3 2020 | $506,000 | -22.2% | 74,481 | -14.0% | 0.00% | – |
Q2 2020 | $650,000 | -5.2% | 86,560 | -20.8% | 0.00% | – |
Q1 2020 | $686,000 | -48.5% | 109,300 | +24.4% | 0.00% | -100.0% |
Q4 2019 | $1,331,000 | -28.1% | 87,851 | -51.3% | 0.00% | 0.0% |
Q3 2019 | $1,852,000 | -45.2% | 180,507 | -21.2% | 0.00% | -50.0% |
Q2 2019 | $3,379,000 | +17.8% | 229,066 | +31.5% | 0.00% | +100.0% |
Q1 2019 | $2,869,000 | +2251.6% | 174,219 | +710.7% | 0.00% | – |
Q4 2018 | $122,000 | -89.6% | 21,491 | -75.2% | 0.00% | -100.0% |
Q2 2018 | $1,172,000 | – | 86,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |